OBJECTIVE: Examine the association between sedentary behavior and psychiatric symptoms among overweight and obese adults with schizophrenia or schizoaffective disorders (SZO/SA). DESIGN: Randomized clinical trial; Weight Assessment and Intervention in Schizophrenia Treatment (WAIST) Study: baseline data collected 2005-2008. SETTING: University of Pittsburgh Medical Center, Pittsburgh, PA, USA. PARTICIPANTS: Community-dwelling adults diagnosed with SZO/SA, with mild symptom severity [Positive and Negative Syndrome Scale (PANSS)<90], who were interested in losing weight, age 18-70years, BMI>27kg/m(2). MEASUREMENTS: Objectively measured sedentary behavior by accelerometry, and psychopathology assessed by PANSS. Participants wore the actigraphs for 7 consecutive days during their waking hours. Sedentary behavior was defined as ≤100 counts per minute during wear-time and excluded sleep and non-wear time. RESULTS: On average, 81% of the participant's monitoring time or 756min/day was classified as sedentary behavior using accelerometry. No association was observed between sedentary behaviors and PANSS psychiatric symptoms [total (p≥0.75), positive (p≥0.81), negative (p≥0.59) and general psychopathology (p≥0.65) subscales]. No association was observed between sedentary behaviors and age, race, gender and BMI. CONCLUSION: From a clinical and public health perspective, the amount of time (approximately 13h) and percentage of time (81% excluding non-wear time associated with sleeping) engaged in sedentary behavior among overweight and obese adults in this population is alarming, and points to an urgent need for interventions to decrease sedentary behaviors. The lack of associations between sedentary behavior and psychiatric symptoms may be due to a ceiling effect for sedentary behavior.
RCT Entities:
OBJECTIVE: Examine the association between sedentary behavior and psychiatric symptoms among overweight and obese adults with schizophrenia or schizoaffective disorders (SZO/SA). DESIGN: Randomized clinical trial; Weight Assessment and Intervention in Schizophrenia Treatment (WAIST) Study: baseline data collected 2005-2008. SETTING: University of Pittsburgh Medical Center, Pittsburgh, PA, USA. PARTICIPANTS: Community-dwelling adults diagnosed with SZO/SA, with mild symptom severity [Positive and Negative Syndrome Scale (PANSS)<90], who were interested in losing weight, age 18-70years, BMI>27kg/m(2). MEASUREMENTS: Objectively measured sedentary behavior by accelerometry, and psychopathology assessed by PANSS. Participants wore the actigraphs for 7 consecutive days during their waking hours. Sedentary behavior was defined as ≤100 counts per minute during wear-time and excluded sleep and non-wear time. RESULTS: On average, 81% of the participant's monitoring time or 756min/day was classified as sedentary behavior using accelerometry. No association was observed between sedentary behaviors and PANSS psychiatric symptoms [total (p≥0.75), positive (p≥0.81), negative (p≥0.59) and general psychopathology (p≥0.65) subscales]. No association was observed between sedentary behaviors and age, race, gender and BMI. CONCLUSION: From a clinical and public health perspective, the amount of time (approximately 13h) and percentage of time (81% excluding non-wear time associated with sleeping) engaged in sedentary behavior among overweight and obese adults in this population is alarming, and points to an urgent need for interventions to decrease sedentary behaviors. The lack of associations between sedentary behavior and psychiatric symptoms may be due to a ceiling effect for sedentary behavior.
Authors: A M Kriska; W C Knowler; R E LaPorte; A L Drash; R R Wing; S N Blair; P H Bennett; L H Kuller Journal: Diabetes Care Date: 1990-04 Impact factor: 19.112
Authors: Matti Joukamaa; Markku Heliövaara; Paul Knekt; Arpo Aromaa; Raimo Raitasalo; Ville Lehtinen Journal: Br J Psychiatry Date: 2006-02 Impact factor: 9.319
Authors: A H Barnett; P Mackin; I Chaudhry; A Farooqi; R Gadsby; A Heald; J Hill; H Millar; R Peveler; A Rees; V Singh; D Taylor; J Vora; P B Jones Journal: J Psychopharmacol Date: 2007-06 Impact factor: 4.153
Authors: D W Dunstan; E L M Barr; G N Healy; J Salmon; J E Shaw; B Balkau; D J Magliano; A J Cameron; P Z Zimmet; N Owen Journal: Circulation Date: 2010-01-11 Impact factor: 29.690
Authors: Laurie A Lindamer; Christine McKibbin; Gregory J Norman; Leslie Jordan; Kelly Harrison; Suranee Abeyesinhe; Kevin Patrick Journal: Schizophr Res Date: 2008-06-12 Impact factor: 4.939
Authors: Carol A Janney; Rohan Ganguli; Caroline R Richardson; Rob G Holleman; Gong Tang; Jane A Cauley; Andrea M Kriska Journal: Schizophr Res Date: 2013-02-12 Impact factor: 4.939
Authors: Bobbi Jo H Yarborough; Nancy A Perrin; Scott P Stumbo; John Muench; Carla A Green Journal: Am J Prev Med Date: 2017-10-19 Impact factor: 5.043
Authors: Nancy H Liu; Gail L Daumit; Tarun Dua; Ralph Aquila; Fiona Charlson; Pim Cuijpers; Benjamin Druss; Kenn Dudek; Melvyn Freeman; Chiyo Fujii; Wolfgang Gaebel; Ulrich Hegerl; Itzhak Levav; Thomas Munk Laursen; Hong Ma; Mario Maj; Maria Elena Medina-Mora; Merete Nordentoft; Dorairaj Prabhakaran; Karen Pratt; Martin Prince; Thara Rangaswamy; David Shiers; Ezra Susser; Graham Thornicroft; Kristian Wahlbeck; Abe Fekadu Wassie; Harvey Whiteford; Shekhar Saxena Journal: World Psychiatry Date: 2017-02 Impact factor: 49.548